Skip to main content

An official website of the United States government

  1. Home
  2. Trade
  3. Programs and Administration
  4. Temporary Duty-Free Treatment of Infant Formula and Infant Formula Base Powder

Temporary Duty-Free Treatment of Infant Formula and Infant Formula Base Powder

In 2022, the President signed the Formula Act (H.R. 8351) and the Bulk Infant Formula to Retail Shelves Act (H.R. 8982). These acts provided for the temporary duty-free treatment of infant formula and infant formula base powder, respectively. Below CSMS messages are CBP's guidance for the implementation of the temporary duty-free treatment. The duty-free treatment expired on December 31, 2022. 

Last Modified: Aug 03, 2023

DHS CBP Logo Seal

You have been selected to participate in a brief survey about your experience today with CBP.gov.